• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA-1273 新型冠状病毒(莫德纳)疫苗接种后健康年轻男性发生心肌炎:病例报告。

Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report.

机构信息

Department of Internal Medicine, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, BDB 327, Birmingham, AL, 35233, USA.

Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

BMC Cardiovasc Disord. 2021 Aug 4;21(1):375. doi: 10.1186/s12872-021-02183-3.

DOI:10.1186/s12872-021-02183-3
PMID:34348657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8334333/
Abstract

BACKGROUND

Half of U.S. adults have received at least one dose of the COVID-19 vaccines produced by either Pfizer, Moderna, or Johnson and Johnson, which represents a major milestone in the ongoing pandemic. Given the emergency use authorizations for these vaccines, their side effects and safety were assessed over a compressed time period. Hence, ongoing monitoring for vaccine-related adverse events is imperative for a full understanding and delineation of their safety profile.

CASE PRESENTATION

An 22-year-old Caucasian male presented to our hospital center complaining of pleuritic chest pain. Six months prior he had a mild case of COVID-19, but was otherwise healthy. He had received his first dose of the Moderna vaccine three days prior to developing symptoms. Laboratory analysis revealed a markedly elevated troponin and multiple imaging modalities during his hospitalization found evidence of wall motion abnormalities consistent with a diagnosis of perimyocarditis. He was started on aspirin and colchicine with marked improvement of his symptoms prior to discharge.

CONCLUSIONS

We present a case of perimyocarditis that was temporally related to COVID-19 mRNA vaccination in an young male with prior COVID-19 infection but otherwise healthy. Our case report highlights an albeit rare but important adverse event for clinicians to be aware of. It also suggests a possible mechanism for the development of myocardial injury in our patient.

摘要

背景

目前,美国已有一半成年人至少接种了一剂辉瑞、莫德纳或强生公司生产的新冠疫苗,这标志着这场持续大流行中的一个重要里程碑。鉴于这些疫苗的紧急使用授权,其副作用和安全性是在压缩的时间内进行评估的。因此,为了全面了解和明确其安全性,持续监测与疫苗相关的不良事件至关重要。

病例介绍

一名 22 岁的白人男性因胸痛来到我们医院中心就诊。他在六个月前曾患有轻度新冠肺炎,但除此之外身体健康。他在出现症状前三天接种了第一剂 Moderna 疫苗。实验室分析显示肌钙蛋白显著升高,住院期间的多种成像方式发现了与心肌炎一致的壁运动异常的证据。他开始服用阿司匹林和秋水仙碱,在出院前症状明显改善。

结论

我们报告了一例心肌炎病例,该病例与一名年轻男性先前的 COVID-19 感染有关,但除此之外身体健康,与 COVID-19 mRNA 疫苗接种在时间上有关。我们的病例报告强调了一种罕见但重要的不良事件,临床医生需要对此有所了解。它还提示了我们患者心肌损伤发展的一种可能机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/719b7fe955e6/12872_2021_2183_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/421872b38b2b/12872_2021_2183_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/e52979d5420e/12872_2021_2183_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/20060d1396f6/12872_2021_2183_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/719b7fe955e6/12872_2021_2183_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/421872b38b2b/12872_2021_2183_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/e52979d5420e/12872_2021_2183_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/20060d1396f6/12872_2021_2183_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e1/8336405/719b7fe955e6/12872_2021_2183_Fig4_HTML.jpg

相似文献

1
Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report.mRNA-1273 新型冠状病毒(莫德纳)疫苗接种后健康年轻男性发生心肌炎:病例报告。
BMC Cardiovasc Disord. 2021 Aug 4;21(1):375. doi: 10.1186/s12872-021-02183-3.
2
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen(强生)和 mRNA COVID-19 疫苗(辉瑞-生物科技和莫德纳)成年受种者发生不良事件后使用 COVID-19 疫苗:免疫实践咨询委员会的更新-美国,2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
3
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告:免疫实践咨询委员会更新-美国,2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
4
COVID-19 mRNA Vaccination-Induced Myopericarditis in an Otherwise Healthy Young Male: An Evidence-Based Approach to Differentiating From Perimyocarditis.一名原本健康的年轻男性接种新冠病毒mRNA疫苗后发生心肌心包炎:基于证据的与心包心肌炎鉴别的方法
Cureus. 2024 May 9;16(5):e59999. doi: 10.7759/cureus.59999. eCollection 2024 May.
5
Case Report of COVID-19 mRNA Vaccine-Associated Myocarditis.COVID-19 mRNA 疫苗相关心肌炎病例报告。
WMJ. 2022 Oct;121(3):E50-E52.
6
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗:辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
7
Acute Perimyocarditis in an Adolescent Japanese Male after a Booster Dose of the BNT162b2 COVID-19 Vaccine.青少年男性接种 BNT162b2 新冠疫苗加强针后出现急性心肌炎。
Tohoku J Exp Med. 2022 Oct 25;258(3):177-182. doi: 10.1620/tjem.2022.J068. Epub 2022 Aug 25.
8
Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination.新型冠状病毒mRNA-1237(Moderna)疫苗接种后急性心包心肌炎的不寻常表现
Cureus. 2021 Jul 23;13(7):e16590. doi: 10.7759/cureus.16590. eCollection 2021 Jul.
9
Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.青少年接种新冠病毒mRNA疫苗后心肌炎的心脏磁共振成像表现
AJR Am J Roentgenol. 2022 Apr;218(4):651-657. doi: 10.2214/AJR.21.26853. Epub 2021 Oct 27.
10
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination.青少年和青年中临床上疑似与新冠病毒疫苗接种存在时间关联的心肌炎:新冠病毒疫苗接种后疑似心肌炎
Circulation. 2022 Feb;145(5):345-356. doi: 10.1161/CIRCULATIONAHA.121.056583. Epub 2021 Dec 6.

引用本文的文献

1
Incidence and management of the main serious adverse events reported after COVID-19 vaccination.报告的 COVID-19 疫苗接种后主要严重不良事件的发生率和处理。
Pharmacol Res Perspect. 2024 Jun;12(3):e1224. doi: 10.1002/prp2.1224.
2
COVID-19 mRNA vaccine-related myocarditis: A PRISMA systematic review, imaging approach and differential diagnoses.新型冠状病毒肺炎信使核糖核酸疫苗相关心肌炎:一项系统评价、影像学方法及鉴别诊断的系统评价(PRISMA)
Radiol Case Rep. 2023 Dec 22;19(3):1008-1019. doi: 10.1016/j.radcr.2023.11.070. eCollection 2024 Mar.
3
COVID-19 vaccine-related myocarditis: Could antipyretic drugs be a trigger?

本文引用的文献

1
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.mRNA COVID-19 疫苗接种后发生急性心肌炎的患者。
JAMA Cardiol. 2021 Oct 1;6(10):1196-1201. doi: 10.1001/jamacardio.2021.2828.
2
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
3
Myocarditis following COVID-19 mRNA vaccination.新冠病毒mRNA疫苗接种后的心肌炎
新冠病毒疫苗相关心肌炎:退热药会是一个触发因素吗?
Infect Med (Beijing). 2023 Mar;2(1):49-50. doi: 10.1016/j.imj.2023.01.004. Epub 2023 Jan 30.
4
Myocarditis Following COVID-19 Vaccination: A Systematic Review.新型冠状病毒肺炎疫苗接种后心肌炎:一项系统评价
Cureus. 2023 Apr 22;15(4):e37999. doi: 10.7759/cureus.37999. eCollection 2023 Apr.
5
Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies.新型冠状病毒疫苗的心血管并发症:病例报告和病例系列研究综述。
Heart Lung. 2023 May-Jun;59:173-180. doi: 10.1016/j.hrtlng.2023.02.003. Epub 2023 Feb 8.
6
Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases.心肌炎与 2019 年冠状病毒病疫苗接种:病例的系统评价和汇总分析。
Biomol Biomed. 2023 Jul 3;23(4):546-567. doi: 10.17305/bb.2022.8779.
7
COVID-19 vaccines adverse events: potential molecular mechanisms.新型冠状病毒肺炎疫苗不良反应:潜在的分子机制。
Immunol Res. 2023 Jun;71(3):356-372. doi: 10.1007/s12026-023-09357-5. Epub 2023 Jan 6.
8
COVID-19 Vaccine-Related Myocardial and Pericardial Inflammation.COVID-19 疫苗相关的心肌和心包炎症。
Curr Cardiol Rep. 2022 Dec;24(12):2031-2041. doi: 10.1007/s11886-022-01801-6. Epub 2022 Nov 28.
9
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
10
Myocarditis Following COVID-19 Vaccination: Cardiac Imaging Findings in 118 Studies.接种 COVID-19 疫苗后的心肌炎:118 项研究中的心脏影像学表现。
Tomography. 2022 Jul 30;8(4):1959-1973. doi: 10.3390/tomography8040164.
Vaccine. 2021 Jun 29;39(29):3790-3793. doi: 10.1016/j.vaccine.2021.05.087. Epub 2021 May 28.
4
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.单剂 SARS-CoV-2 mRNA 疫苗接种后血清阳性者的抗体反应。
N Engl J Med. 2021 Apr 8;384(14):1372-1374. doi: 10.1056/NEJMc2101667. Epub 2021 Mar 10.
5
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
6
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study.COVID-19 相关心肌损伤的病理特征:一项多中心心血管病理学研究。
Eur Heart J. 2020 Oct 14;41(39):3827-3835. doi: 10.1093/eurheartj/ehaa664.
7
Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management.识别 COVID-19 相关心肌炎:可能的病理生理学及诊断和管理建议指南。
Heart Rhythm. 2020 Sep;17(9):1463-1471. doi: 10.1016/j.hrthm.2020.05.001. Epub 2020 May 5.
8
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.人类心脏中的 ACE2 表达表明了 SARS-CoV-2 感染患者心脏损伤的新潜在机制。
Cardiovasc Res. 2020 May 1;116(6):1097-1100. doi: 10.1093/cvr/cvaa078.
9
Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review.急性和复发性心包炎的管理:美国心脏病学会杂志最新技术综述
J Am Coll Cardiol. 2020 Jan 7;75(1):76-92. doi: 10.1016/j.jacc.2019.11.021.
10
Management of Myocarditis-Related Cardiomyopathy in Adults.成人心肌炎相关性心肌病的管理。
Circ Res. 2019 May 24;124(11):1568-1583. doi: 10.1161/CIRCRESAHA.118.313578.